Glow Completes Buildout of Canadian Facility and Begins Commissioning Proprietary Reactor
News
09 . 11 . 2021
27 . 10 . 2021
Glow Engages Regulatory Consultant Firms to Advance Commercialization of Artemic™ and Other Nutraceutical Ingredients in U.S. and Mexico
26 . 10 . 2021
Glow Takes Receipt of MyCell® Reactor for Prototyping and Formulation for Canadian Processing; Receives CSA Standards Approval
15 . 10 . 2021
Glow Lifetech Strengthens Management Team with Manufacturing and Product Development Leaders; Provides Management Overview
16 . 08 . 2021
Glow LifeTech Announces Upgrade to OTCQB Under Ticker ‘GLWLF’
10 . 08 . 2021
Glow Acquires Strategic Equity Investment in Nova Mentis
28 . 05 . 2021
Glow LifeTech Secures Canadian Processing Facility; Begins Build-out to Produce Next-Generation Cannabis Ingredients
11 . 05 . 2021
Glow LifeTech Reports on Additional Research Results on ArtemiC™ and Positive Implications for COVID-19 Variants